Determining the Prevalence of Frailty and Evaluating Its Relationship With Mortality.

NCT06330883 | Completed

• 1 other identifier: 2021/507
• Study Type: observational
• Target: 148
• Locations: 1 country
• Sites: 1

Brief Summary

Covid-19 patients admitted to the intensive care unit of Selcuk University Hospital were included in the study. Clinical frailty score was given during admission to the intensive care unit. Demographic data, laboratory data, radiological imaging and vital signs of the patients were recorded. Treatment and patient positions were recorded during the intensive care follow-up of the patients. Mortality status of the patients 6 months after admission to the ICU was recorded.

Conditions

Frailty; Mortality; COVID-19

Outcome Measures

Primary Outcomes (1)

• Mortality

  Mortality rate in the first 6 months after inyensive care unit admission

  6 months

Secondary Outcomes (8)

• The Sequential Organ Failure Assessment Score, The Acute Physiology and Chronic Health Evaluation II Score

  First 24 hours after admission intensive care unit

• Thorax computed tomography (CT) imaging

  Within 2 weeks prior to admission ICU

• Laboratory values

  Routine values at admission ICU

• Respiratory support

  As long as the patient stays in the intensive care unit

• Vasoactive drugs administered

  Data will be collected from the admission to the intensive care unit up to 6 months or until mortality within this period.

Study Arms (2)

Frail

Patients will be evaluated frail if the clinical frailty score is ≥5

Diagnostic Test: Prognosis

non-fragile

Patients will be evaluated non-fragile if the clinical frailty score is \<5.

Diagnostic Test: Prognosis

Interventions

Prognosis DIAGNOSTIC_TEST

survival/mortalite

Frail; non-fragile

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

It is planned to include non-pregnant and non-traumatic patients over the age of 18 who are treated with the diagnosis of COVID-19 in the Intensive Care Unit of Selcuk University hospital.

You may qualify if:

• Patients who over the age of 18
• Patients who diagnosed with Covid-19

You may not qualify if:

• Trauma patient
• Pregnant

Sponsors & Collaborators

• Selcuk University: lead

Study Sites (1)

Selcuk University Hospital

Konya, Selçuklu, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Frailty; COVID-19

Interventions

Prognosis

Condition Hierarchy (Ancestors)

Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pneumonia, Viral; Pneumonia; Respiratory Tract Infections; Infections; Virus Diseases; Coronavirus Infections; Coronaviridae Infections; Nidovirales Infections; RNA Virus Infections; Lung Diseases; Respiratory Tract Diseases

Intervention Hierarchy (Ancestors)

Diagnosis

Study Officials

• Jale Bengi Çelik

  Selcuk University Hospital, Department of Anesthesiology and Reanimation, jalecelik@hotmail.com

  STUDY DIRECTOR

Study Design

• Study Type: observational
• Observational Model: CASE CONTROL
• Time Perspective: PROSPECTIVE
• Target Duration: 6 Months
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Research Assistant

Study Record Dates

• First Submitted: May 23, 2023
• First Posted: March 26, 2024
• Study Start: January 1, 2022
• Primary Completion: January 1, 2023
• Study Completion: January 1, 2023
• Last Updated: March 26, 2024

Record last verified: 2024-03

Data Sharing

• IPD Sharing: Will not share

Locations

TU (1)